
Global Glabridin (CAS 59870-68-7) Competitive Landscape Professional Research Report 2025
Description
Research Summary
Glabridin (CAS 59870-68-7) is a natural compound extracted from the root of licorice (Glycyrrhiza glabra) and is known for its various biological activities. This plant-derived substance is commonly used in cosmetics and skincare products due to its skin-brightening and anti-inflammatory properties. Glabridin inhibits tyrosinase, an enzyme involved in the production of melanin, making it a sought-after ingredient in formulations aiming to lighten hyperpigmentation and even out skin tone. Additionally, glabridin exhibits antioxidant effects, providing potential benefits for protecting the skin against oxidative stress. The compound has garnered attention in the cosmetic and pharmaceutical industries for its potential role in promoting skin health and addressing various dermatological concerns.
According to DIResearch's in-depth investigation and research, the global Glabridin (CAS 59870-68-7) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Glabridin (CAS 59870-68-7) include Sabinsa, Alchem International, MAFCO, Plamed Green Science Group, Xi'an Zhongying, Spring Autumn Biological, Huaian Brothers Biotechnology, Xi’an Tianye Biotech, SK Bioland, Maruzen Pharmaceuticals, Sunpure Extracts etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Glabridin (CAS 59870-68-7). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Glabridin (CAS 59870-68-7) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Glabridin (CAS 59870-68-7) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Glabridin (CAS 59870-68-7) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Glabridin (CAS 59870-68-7) Include:
Sabinsa
Alchem International
MAFCO
Plamed Green Science Group
Xi'an Zhongying
Spring Autumn Biological
Huaian Brothers Biotechnology
Xi’an Tianye Biotech
SK Bioland
Maruzen Pharmaceuticals
Sunpure Extracts
Glabridin (CAS 59870-68-7) Product Segment Include:
20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Other
Glabridin (CAS 59870-68-7) Product Application Include:
Cosmetic
Pharmaceutical
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Glabridin (CAS 59870-68-7) Capacity and Production Analysis
Chapter 3: Global Glabridin (CAS 59870-68-7) Industry PESTEL Analysis
Chapter 4: Global Glabridin (CAS 59870-68-7) Industry Porter's Five Forces Analysis
Chapter 5: Global Glabridin (CAS 59870-68-7) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Glabridin (CAS 59870-68-7) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Glabridin (CAS 59870-68-7) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Glabridin (CAS 59870-68-7) is a natural compound extracted from the root of licorice (Glycyrrhiza glabra) and is known for its various biological activities. This plant-derived substance is commonly used in cosmetics and skincare products due to its skin-brightening and anti-inflammatory properties. Glabridin inhibits tyrosinase, an enzyme involved in the production of melanin, making it a sought-after ingredient in formulations aiming to lighten hyperpigmentation and even out skin tone. Additionally, glabridin exhibits antioxidant effects, providing potential benefits for protecting the skin against oxidative stress. The compound has garnered attention in the cosmetic and pharmaceutical industries for its potential role in promoting skin health and addressing various dermatological concerns.
According to DIResearch's in-depth investigation and research, the global Glabridin (CAS 59870-68-7) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Glabridin (CAS 59870-68-7) include Sabinsa, Alchem International, MAFCO, Plamed Green Science Group, Xi'an Zhongying, Spring Autumn Biological, Huaian Brothers Biotechnology, Xi’an Tianye Biotech, SK Bioland, Maruzen Pharmaceuticals, Sunpure Extracts etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Glabridin (CAS 59870-68-7). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Glabridin (CAS 59870-68-7) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Glabridin (CAS 59870-68-7) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Glabridin (CAS 59870-68-7) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Glabridin (CAS 59870-68-7) Include:
Sabinsa
Alchem International
MAFCO
Plamed Green Science Group
Xi'an Zhongying
Spring Autumn Biological
Huaian Brothers Biotechnology
Xi’an Tianye Biotech
SK Bioland
Maruzen Pharmaceuticals
Sunpure Extracts
Glabridin (CAS 59870-68-7) Product Segment Include:
20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Other
Glabridin (CAS 59870-68-7) Product Application Include:
Cosmetic
Pharmaceutical
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Glabridin (CAS 59870-68-7) Capacity and Production Analysis
Chapter 3: Global Glabridin (CAS 59870-68-7) Industry PESTEL Analysis
Chapter 4: Global Glabridin (CAS 59870-68-7) Industry Porter's Five Forces Analysis
Chapter 5: Global Glabridin (CAS 59870-68-7) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Glabridin (CAS 59870-68-7) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Glabridin (CAS 59870-68-7) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Glabridin (CAS 59870-68-7) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Glabridin (CAS 59870-68-7) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Glabridin (CAS 59870-68-7) Product by Type
- 1.2.1 20% (HPLC)
- 1.2.2 40% (HPLC)
- 1.2.3 60% (HPLC)
- 1.2.4 90% (HPLC)
- 1.2.5 98% (HPLC)
- 1.2.6 Other
- 1.3 Glabridin (CAS 59870-68-7) Product by Application
- 1.3.1 Cosmetic
- 1.3.2 Pharmaceutical
- 1.4 Global Glabridin (CAS 59870-68-7) Market Revenue and Sales Analysis
- 1.4.1 Global Glabridin (CAS 59870-68-7) Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Glabridin (CAS 59870-68-7) Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Glabridin (CAS 59870-68-7) Market Sales Price Trend Analysis (2020-2032)
- 1.5 Glabridin (CAS 59870-68-7) Industry Trends and Innovation
- 1.5.1 Glabridin (CAS 59870-68-7) Industry Trends and Innovation
- 1.5.2 Glabridin (CAS 59870-68-7) Market Drivers and Challenges
- 2 Global Glabridin (CAS 59870-68-7) Capacity and Production Analysis
- 2.1 Global Glabridin (CAS 59870-68-7) Capacity, Production and Utilization (2020-2032)
- 2.2 Global Glabridin (CAS 59870-68-7) Production Growth Trend by Region: 2024 VS 2025 VS 2030
- 2.3 Global Glabridin (CAS 59870-68-7) Production by Region
- 2.3.1 Global Glabridin (CAS 59870-68-7) Production by Region (2020-2025)
- 2.3.2 Global Glabridin (CAS 59870-68-7) Production Forecast by Region (2026-2032)
- 2.3.3 Global Glabridin (CAS 59870-68-7) Production Market Share by Region (2020-2032)
- 3 Glabridin (CAS 59870-68-7) Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Glabridin (CAS 59870-68-7) Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Glabridin (CAS 59870-68-7) Market Analysis by Regions
- 5.1 Glabridin (CAS 59870-68-7) Overall Market: 2024 VS 2025 VS 2032
- 5.2 Global Glabridin (CAS 59870-68-7) Revenue and Forecast Analysis (2020-2032)
- 5.2.1 Global Glabridin (CAS 59870-68-7) Revenue and Market Share by Region (2020-2025)
- 5.2.2 Global Glabridin (CAS 59870-68-7) Revenue and Market Forecast by Region (2026-2032)
- 5.3 Global Glabridin (CAS 59870-68-7) Sales and Forecast Analysis (2020-2032)
- 5.3.1 Global Glabridin (CAS 59870-68-7) Sales and Market Share by Region (2020-2025)
- 5.3.2 Global Glabridin (CAS 59870-68-7) Sales and Market Forecast by Region (2026-2032)
- 5.4 Global Glabridin (CAS 59870-68-7) Sales Price Trend Analysis (2020-2032)
- 6 Global Glabridin (CAS 59870-68-7) Market Size by Type and Application
- 6.1 Global Glabridin (CAS 59870-68-7) Market Size by Type
- 6.1.1 Global Glabridin (CAS 59870-68-7) Revenue and Forecast Analysis by Type (2020-2032)
- 6.1.2 Global Glabridin (CAS 59870-68-7) Sales and Forecast Analysis by Type (2020-2032)
- 6.2 Global Glabridin (CAS 59870-68-7) Market Size by Application
- 6.2.1 Global Glabridin (CAS 59870-68-7) Revenue and Forecast Analysis by Application (2020-2032)
- 6.2.2 Global Glabridin (CAS 59870-68-7) Sales and Forecast Analysis by Application (2020-2032)
- 7 North America
- 7.1 North America Glabridin (CAS 59870-68-7) Market Size and Growth Rate Analysis (2020-2032)
- 7.2 North America Key Manufacturers Analysis
- 7.3 North America Glabridin (CAS 59870-68-7) Market Size by Type
- 7.3.1 North America Glabridin (CAS 59870-68-7) Sales by Type (2020-2032)
- 7.3.2 North America Glabridin (CAS 59870-68-7) Revenue by Type (2020-2032)
- 7.4 North America Glabridin (CAS 59870-68-7) Market Size by Application
- 7.4.1 North America Glabridin (CAS 59870-68-7) Sales by Application (2020-2032)
- 7.4.2 North America Glabridin (CAS 59870-68-7) Revenue by Application (2020-2032)
- 7.5 North America Glabridin (CAS 59870-68-7) Market Size by Country
- 7.5.1 US
- 7.5.2 Canada
- 8 Europe
- 8.1 Europe Glabridin (CAS 59870-68-7) Market Size and Growth Rate Analysis (2020-2032)
- 8.2 Europe Key Manufacturers Analysis
- 8.3 Europe Glabridin (CAS 59870-68-7) Market Size by Type
- 8.3.1 Europe Glabridin (CAS 59870-68-7) Sales by Type (2020-2032)
- 8.3.2 Europe Glabridin (CAS 59870-68-7) Revenue by Type (2020-2032)
- 8.4 Europe Glabridin (CAS 59870-68-7) Market Size by Application
- 8.4.1 Europe Glabridin (CAS 59870-68-7) Sales by Application (2020-2032)
- 8.4.2 Europe Glabridin (CAS 59870-68-7) Revenue by Application (2020-2032)
- 8.5 Europe Glabridin (CAS 59870-68-7) Market Size by Country
- 8.5.1 Germany
- 8.5.2 France
- 8.5.3 United Kingdom
- 8.5.4 Italy
- 8.5.5 Spain
- 8.5.6 Benelux
- 9 China
- 9.1 China Glabridin (CAS 59870-68-7) Market Size and Growth Rate Analysis (2020-2032)
- 9.2 China Key Manufacturers Analysis
- 9.3 China Glabridin (CAS 59870-68-7) Market Size by Type
- 9.3.1 China Glabridin (CAS 59870-68-7) Sales by Type (2020-2032)
- 9.3.2 China Glabridin (CAS 59870-68-7) Revenue by Type (2020-2032)
- 9.4 China Glabridin (CAS 59870-68-7) Market Size by Application
- 9.4.1 China Glabridin (CAS 59870-68-7) Sales by Application (2020-2032)
- 9.4.2 China Glabridin (CAS 59870-68-7) Revenue by Application (2020-2032)
- 10 APAC (excl. China)
- 10.1 APAC (excl. China) Glabridin (CAS 59870-68-7) Market Size and Growth Rate Analysis (2020-2032)
- 10.2 APAC (excl. China) Key Manufacturers Analysis
- 10.3 APAC (excl. China) Glabridin (CAS 59870-68-7) Market Size by Type
- 10.3.1 APAC (excl. China) Glabridin (CAS 59870-68-7) Sales by Type (2020-2032)
- 10.3.2 APAC (excl. China) Glabridin (CAS 59870-68-7) Revenue by Type (2020-2032)
- 10.4 APAC (excl. China) Glabridin (CAS 59870-68-7) Market Size by Application
- 10.4.1 APAC (excl. China) Glabridin (CAS 59870-68-7) Sales by Application (2020-2032)
- 10.4.2 APAC (excl. China) Glabridin (CAS 59870-68-7) Revenue by Application (2020-2032)
- 10.5 APAC (excl. China) Glabridin (CAS 59870-68-7) Market Size by Country
- 10.5.1 Japan
- 10.5.2 South Korea
- 10.5.3 India
- 10.5.4 Australia
- 10.5.5 Southeast Asia
- 11 Latin America
- 11.1 Latin America Glabridin (CAS 59870-68-7) Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Latin America Key Manufacturers Analysis
- 1`.3 Latin America Glabridin (CAS 59870-68-7) Market Size by Type
- 11.3.1 Latin America Glabridin (CAS 59870-68-7) Sales by Type (2020-2032)
- 11.3.2 Latin America Glabridin (CAS 59870-68-7) Revenue by Type (2020-2032)
- 11.4 Latin America Glabridin (CAS 59870-68-7) Market Size by Application
- 11.4.1 Latin America Glabridin (CAS 59870-68-7) Sales by Application (2020-2032)
- 11.4.2 Latin America Glabridin (CAS 59870-68-7) Revenue by Application (2020-2032)
- 11.5 Latin America Glabridin (CAS 59870-68-7) Market Size by Country
- 11.6 Latin America Glabridin (CAS 59870-68-7) Market Size by Country
- 11.6.1 Mexico
- 11.6.2 Brazil
- 12 Middle East & Africa
- 12.1 Middle East & Africa Glabridin (CAS 59870-68-7) Market Size and Growth Rate Analysis (2020-2032)
- 12.2 Middle East & Africa Key Manufacturers Analysis
- 12.3 Middle East & Africa Glabridin (CAS 59870-68-7) Market Size by Type
- 12.3.1 Middle East & Africa Glabridin (CAS 59870-68-7) Sales by Type (2020-2032)
- 12.3.2 Middle East & Africa Glabridin (CAS 59870-68-7) Revenue by Type (2020-2032)
- 12.4 Middle East & Africa Glabridin (CAS 59870-68-7) Market Size by Application
- 12.4.1 Middle East & Africa Glabridin (CAS 59870-68-7) Sales by Application (2020-2032)
- 12.4.2 Middle East & Africa Glabridin (CAS 59870-68-7) Revenue by Application (2020-2032)
- 12.5 Middle East Glabridin (CAS 59870-68-7) Market Size by Country
- 12.5.1 Saudi Arabia
- 12.5.2 South Africa
- 13 Competition by Manufacturers
- 13.1 Global Glabridin (CAS 59870-68-7) Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 13.1.1 Global Glabridin (CAS 59870-68-7) Market Sales by Key Manufacturers (2021-2025)
- 13.1.2 Global Glabridin (CAS 59870-68-7) Market Revenue by Key Manufacturers (2021-2025)
- 13.1.3 Global Glabridin (CAS 59870-68-7) Average Sales Price by Manufacturers (2021-2025)
- 13.2 Glabridin (CAS 59870-68-7) Competitive Landscape Analysis and Market Dynamic
- 13.2.1 Glabridin (CAS 59870-68-7) Competitive Landscape Analysis
- 13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 13.2.3 Market Dynamic
- 14 Key Companies Analysis
- 14.1 Sabinsa
- 14.1.1 Sabinsa Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.1.2 Sabinsa Glabridin (CAS 59870-68-7) Product Portfolio
- 14.1.3 Sabinsa Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.2 Alchem International
- 14.2.1 Alchem International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.2.2 Alchem International Glabridin (CAS 59870-68-7) Product Portfolio
- 14.2.3 Alchem International Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.3 MAFCO
- 14.3.1 MAFCO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.3.2 MAFCO Glabridin (CAS 59870-68-7) Product Portfolio
- 14.3.3 MAFCO Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.4 Plamed Green Science Group
- 14.4.1 Plamed Green Science Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.4.2 Plamed Green Science Group Glabridin (CAS 59870-68-7) Product Portfolio
- 14.4.3 Plamed Green Science Group Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.5 Xi'an Zhongying
- 14.5.1 Xi'an Zhongying Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.5.2 Xi'an Zhongying Glabridin (CAS 59870-68-7) Product Portfolio
- 14.5.3 Xi'an Zhongying Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.6 Spring Autumn Biological
- 14.6.1 Spring Autumn Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.6.2 Spring Autumn Biological Glabridin (CAS 59870-68-7) Product Portfolio
- 14.6.3 Spring Autumn Biological Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.7 Huaian Brothers Biotechnology
- 14.7.1 Huaian Brothers Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.7.2 Huaian Brothers Biotechnology Glabridin (CAS 59870-68-7) Product Portfolio
- 14.7.3 Huaian Brothers Biotechnology Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.8 Xi’an Tianye Biotech
- 14.8.1 Xi’an Tianye Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.8.2 Xi’an Tianye Biotech Glabridin (CAS 59870-68-7) Product Portfolio
- 14.8.3 Xi’an Tianye Biotech Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.9 SK Bioland
- 14.9.1 SK Bioland Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.9.2 SK Bioland Glabridin (CAS 59870-68-7) Product Portfolio
- 14.9.3 SK Bioland Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.10 Maruzen Pharmaceuticals
- 14.10.1 Maruzen Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.10.2 Maruzen Pharmaceuticals Glabridin (CAS 59870-68-7) Product Portfolio
- 14.10.3 Maruzen Pharmaceuticals Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.11 Sunpure Extracts
- 14.11.1 Sunpure Extracts Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.11.2 Sunpure Extracts Glabridin (CAS 59870-68-7) Product Portfolio
- 14.11.3 Sunpure Extracts Glabridin (CAS 59870-68-7) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 15 Industry Chain Analysis
- 15.1 Glabridin (CAS 59870-68-7) Industry Chain Analysis
- 15.2 Glabridin (CAS 59870-68-7) Industry Raw Material and Suppliers Analysis
- 15.2.1 Glabridin (CAS 59870-68-7) Key Raw Material Supply Analysis
- 15.2.2 Raw Material Suppliers and Contact Information
- 15.3 Glabridin (CAS 59870-68-7) Typical Downstream Customers
- 15.4 Glabridin (CAS 59870-68-7) Sales Channel Analysis
- 16 Research Findings and Conclusion
- 17 Methodology and Data Source
- 17.1 Methodology/Research Approach
- 17.2 Research Scope
- 17.3 Benchmarks and Assumptions
- 17.4 Date Source
- 17.4.1 Primary Sources
- 17.4.2 Secondary Sources
- 17.5 Data Cross Validation
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.